Skip to content

Intestinal Flora of ADPKD and Prostate Cancer

Intestinal Flora of ADPKD and Prostate Cancer - IFPPC-study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021161
Enrollment
130
Registered
2016-03-01
Start date
2016-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autosomal dominant polycystic kidney disease (ADPKD) Prostate Cancer

Interventions

None listed

Sponsors

Endowed course for the study of polycystic kidney disease, Juntendo University, Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1: ADPKD 2: Newly diagnosed -prostate cancer patients who need hormonal therapy

Exclusion criteria

Exclusion criteria: 1: Taking antibiotics or Immunosuppressive agent 2: Past history of operation of intestinal (without Endoscopic surgery ) 3: Severe intestinal disease 4: Without Informed consent 5: Assessed as unsuitable as research subjects by medical doctor

Design outcomes

Primary

MeasureTime frame
Metagenomic analysis and Metabolome analysis of Intestinal flora before, 2weeks, 1months, 3months, 6months, 12months

Secondary

MeasureTime frame
Renal function Kidney volume PSA

Countries

Japan

Contacts

Public ContactHaruna Kawano

Juntendo University, Graduate School of Medicine Endowed course for the study of polycystic kidney disease

harunase@juntendo.ac.jp0358021227

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026